CARLSBAD, Calif., May 6, 2025 /PRNewswire/ — DCN Dx, a specialist in lateral flow diagnostics development, manufacturing, and IVD regulatory consulting and clinical research, has launched its newly redesigned website, offering improved navigation, a streamlined user experience, and an authentic look at the people behind the company’s success.
The updated site, DCNDx.com, features a more intuitive layout, making it easier for visitors to access educational resources, company updates, and product information. DCNovations products remain available for online purchase through a simplified interface.
In a move that reflects DCN Dx’s transparent and people-first culture, the site now features real DCN Dx staff throughout its pages—reinforcing the company’s commitment to expertise, collaboration, and the personal touch it brings to every partnership.
“We’re proud to launch a site that not only makes it easier for users to find what they need, but also puts our team front and center,” said Charlie Mamrak, Chief Executive Officer at DCN Dx. “This redesign reflects who we are as a company—dedicated, approachable, and focused on delivering results for our partners.”
“This isn’t just a new coat of paint—it’s a smarter, more connected way to engage with the diagnostics community,” added Mitzi Rettinger, Chief Revenue Officer. “Whether you’re looking for insight, innovation, or real-world experience, our new site is built to support those conversations.”
To explore the redesigned website and learn more about DCN Dx’s capabilities, visit DCNDx.com.
About DCN Dx
DCN Dx, based in Carlsbad, California, specializes in lateral flow diagnostics development, manufacturing, and IVD regulatory consulting and clinical research. DCN Dx’s multidisciplinary CDMO specializes in creating tailored assay systems, consumables, and instruments for point-of-use applications, with a particular expertise in lateral flow assays. Their clinical research services group specializes in the planning, execution, and oversight of IVD clinical trials, inclusive of clinical operations, data management, and biostatistics, and regulatory services.
DCN Dx’s personalized approach to IVD product development and clinical trials has supported hundreds of programs and clients. They can oversee every stage from concept to assay development and platform integration, through clinical trials to manufacturing or only handle the aspects you request. In addition to lateral flow assays, DCN Dx’s clinical research expertise extends to any in vitro diagnostic, all with a focus on innovation, usability, and performance.
With a commitment to quality, customer satisfaction, and industry-leading expertise, DCN Dx is setting the benchmark for excellence in IVD services. To learn more about how we can support your diagnostic needs, visit dcndx.com.
For more information contact:
Mitzi Rettinger
Chief Revenue Officer, DCN Dx
Main: (760) 804-3886
Mobile: (512) 431-5836
394723@email4pr.com
SOURCE DCN Dx
NEW YORK--(BUSINESS WIRE)--Vent Creativity, a medical technology company advancing AI-enabled surgical planning, today announced the…
AEON Clinic Elevates Dubai to Global Hub for Longevity Science, A Definitive Four-Day Summit Defining…
Black Book outlines an AI-era integrity architecture for healthcare benchmarking, instrumentation hardening, tiered verification, real-time…
Bagsværd, Denmark, 31 January 2026 – Thomas Rantzau, employee representative on the Board of Directors since…
Baltimore, Maryland, Jan. 31, 2026 (GLOBE NEWSWIRE) -- After sustaining water damage during the massive…
Science-Backed Spermidine Ritual Brings Cellular Renewal to a High-Performance Cultural Moment Primeadine Longevity Shot Primeadine…